Covid

Doctors say Massachusetts is making good progress, but speeding up the shots could be key to stopping the pandemic.

Lots of work going on today, so let me just send the readership to this excellent article about Novavax, by Jason Mast at Endpoints. That vaccine has moved into even more prominence lately with the recent adenovirus vaccine events, and it seems clear that it could be a big part of getting the world

For fully vaccinated people, the risk of still getting Covid-19 remains extremely low, a new study finds.

In the U.S., more than 3m jabs have been given daily for two weeks, on a seven-day rolling average, with 40 percent of adults having gotten one shot and 25% now fully vaccinated. [A] slight dip in …

The U.S. Food and Drug Administration has completed its inspection of the Baltimore-based Johnson & Johnson vaccine maker Emergent BioSolutions Tuesday and "cited a number of observations concerning whether the facility’s processes met our requirements and standards."

Thinking of recommencing business travel? The CDC would like you to consider that airlines may not be the greatest purveyors of Covid-related science.

A third shot is not currently required but could offer additional immunity against coronavirus variants.

Can't find a COVID vaccine appointment in Massachusetts? You may want to try looking up north.

The state opened up coronavirus vaccinations to 1.7 million more people Monday.

There were 1,279 coronavirus cases among students and staff in Massachusetts schools in the last week.

Pfizer CEO Albert Bourla said people will "likely" need a third dose of a Covid-19 vaccine within 12 months of getting fully vaccinated.

The study found that the spread of COVID-19 was reduced by anywhere from 23% to 57% when airlines left the middle seat vacant, compared to when they operated at full capacity.

"The odds might be small, but since vaccines still aren't 100 percent effective, it's not unusual."

Moderna said new data shows its COVID-19 vaccine continues to provide strong protection.

Experts say there are a number of reasons why someone can become infected with COVID-19 even after getting their shot.

Next up on the vaccine news front are some concerns about efficacy. In a very surprising statement, Gao Fu (the head of the Chinese Center for Disease Control and Prevention) said at a conference in Chengdu over the weekend that that the protection figures of the Chinese vaccines are "not high". He

We have a lot of vaccine news to catch up on! First up is the latest on the possible clotting side effects seen with Oxford/AstraZeneca. This is looking more and more likely to be a rare-but-real effect, and I'm not happy that it's holding up. I had hoped at first that this was a false signal, but a

In previous studies, antibodies had to be given intravenously. This one can be given with an under-the-skin injection.

Some scientists suggest halving the dose might reduce risks and help protect more people from COVID-19

Scientists at GE Research have been awarded a grant to develop tiny sensors that can be embedded inside phones to identify COVID-19 particles on surfaces.

Moderna said it's COVID-19 vaccine offers protection for at least six months.

The New York Times has a good story on the problems at the Emergent vaccine plant in Baltimore, following up on this one. They've uncovered a report from last summer that warned that the facility had quality control problems: A copy of the official’s assessment, obtained by The New York Times, ci

A number of Walmart stores in Massachusetts will begin offering COVID vaccine appointments starting next week.

Six months after being diagnosed with Covid-19, 1 in 3 patients had also experienced a neuropsychiatric illness.

With about 16% of the US population fully vaccinated and cases of Covid around five times less than it was at its peak in January, things are looking up when it comes to beating the pandemic. Right…

In a study of 2,260 U.S. volunteers ages 12 to 15, preliminary data showed there were no cases of COVID-19 among fully vaccinated adolescents.

A concerning contributor to the national rise in cases comes from Michigan and the entire Northeast.

It’s a slight drop from earlier this week.

This morning brings news of new trial results of the AZ/Oxford vaccine, with results from the US, Chile, and Peru. This one has been a much more complicated and difficult story than it really should have been - at least, I think that's how it's going to look years from now. As you'll likely remember

In a U.S. trial, the two-dose vaccine reduced symptomatic disease by 79% and severe Covid-19 and hospitalization by 100%.